Roche's COVID-19 hopeful Actemra soars amid pandemic as Lucentis, Ocrevus falter

22nd April 2020 Uncategorised 0

At first glance, Roche’s business has been steady during the COVID-19 crisis. But below the surface, executives still warn of volatilities, though not all of them are bad.

More: Roche's COVID-19 hopeful Actemra soars amid pandemic as Lucentis, Ocrevus falter
Source: fierce